UNH UnitedHealth Group
An unrivaled healthcare toll road at trough margins, but Washington controls the toll; the price already assumes recovery.
The business
UnitedHealth runs the largest US health insurer (UnitedHealthcare: employer, Medicare Advantage, Medicaid) and Optum, which includes the Optum Rx pharmacy benefit manager, Optum Health's physician and value-based care network, and Optum Insight's data and claims software. It collects premiums and fees, pays medical and drug costs, and keeps a thin margin on very large volume. Optum also earns money from services it sells back to UnitedHealthcare and to other payers.
Quality gate · 71/100
Moat & management
| Moat | narrow moat |
| Source | scale |
| Trajectory | eroding |
| Management | adequate |
Its scale gives it real advantages: provider network discounts, purchasing power in the PBM, a huge pool of data, and integration across insurer and provider that rivals can't easily copy. But the parts that earn the excess returns, Medicare Advantage risk-adjustment economics and PBM spreads, depend on government policy. They are now being squeezed by V28 coding changes, PBM reform and DOJ scrutiny, so the moat is regulatory-dependent and has been eroding since 2024.
Over a long period it reinvested well into Optum, and buybacks have shrunk the share count about 1% a year. However, the 2024-25 period showed it underpriced medical cost trend, overpaid for physician-practice roll-ups, and lost credibility, which forced a CEO change and a guidance reset. Debt of about 2x EBITDA is manageable but higher than it used to be.
Owner-earnings inputs
| Owner earnings (TTM) | 15.01B |
| Owner-earnings yield | 4.4% |
| Free-cash-flow yield | 7.0% |
| Growth used (normalized) | 9.0% |
| Market-implied growth (reverse DCF) | 9.5% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 9.0% |
Projected owner earnings
| Yr | Owner earnings | Growth | PV |
|---|---|---|---|
| 1 | 16.36B | 9.0% | 15.01B |
| 2 | 17.72B | 8.3% | 14.92B |
| 3 | 19.08B | 7.7% | 14.73B |
| 4 | 20.41B | 7.0% | 14.46B |
| 5 | 21.71B | 6.3% | 14.11B |
| 6 | 22.94B | 5.7% | 13.68B |
| 7 | 24.08B | 5.0% | 13.18B |
| 8 | 25.13B | 4.3% | 12.61B |
| 9 | 26.05B | 3.7% | 11.99B |
| 10 | 26.83B | 3.0% | 11.33B |
Key risks
- Medicare Advantage rate pressure and risk-adjustment reform (V28) permanently compress margins in its most profitable segment
- DOJ and regulatory action on MA billing, the PBM and vertical integration, possibly including a forced Optum separation
- Medical cost trend stays above premium pricing, and Optum Health's value-based care losses persist
Catalysts
- Margins recover from a trough operating margin of about 4.7% toward the historical 7-8% as repricing and benefit cuts take hold
- Medicare Advantage rate notices improve and the DOJ investigation is resolved without structural remedies
⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~10%/yr owner-earnings growth over 10y (reverse DCF); model credits 9%.